Caroline L. Bellac

1.6k total citations
18 papers, 1.1k citations indexed

About

Caroline L. Bellac is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Caroline L. Bellac has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Caroline L. Bellac's work include Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Tryptophan and brain disorders (4 papers). Caroline L. Bellac is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Tryptophan and brain disorders (4 papers). Caroline L. Bellac collaborates with scholars based in Switzerland, Canada and Germany. Caroline L. Bellac's co-authors include Christopher M. Overall, Amanda E. Starr, Jennifer H. Cox, Antoine Dufour, Stephen L. Leib, Alain Doucet, Richard A. Dean, Verena Goebeler, Ulrich auf dem Keller and Roney S. Coimbra and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Caroline L. Bellac

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline L. Bellac Switzerland 17 374 301 291 231 133 18 1.1k
Marika Christodoulou United Kingdom 4 422 1.1× 460 1.5× 319 1.1× 288 1.2× 191 1.4× 4 1.2k
Paul D. Lira United States 9 324 0.9× 153 0.5× 290 1.0× 449 1.9× 68 0.5× 14 1.2k
Jialiang Hu China 15 634 1.7× 707 2.3× 434 1.5× 154 0.7× 190 1.4× 31 1.4k
Thomas J. Owen United Kingdom 17 643 1.7× 205 0.7× 288 1.0× 93 0.4× 157 1.2× 37 1.2k
Yan Fan United States 21 841 2.2× 177 0.6× 293 1.0× 316 1.4× 50 0.4× 37 1.5k
Annapaola Andolfo Italy 22 716 1.9× 340 1.1× 220 0.8× 134 0.6× 156 1.2× 49 1.5k
Cheikh Menaa United States 21 751 2.0× 202 0.7× 702 2.4× 294 1.3× 77 0.6× 25 1.6k
Alla Pritsker United States 13 460 1.2× 237 0.8× 176 0.6× 334 1.4× 39 0.3× 18 1.3k
Dirk Mielenz Germany 26 750 2.0× 122 0.4× 176 0.6× 702 3.0× 89 0.7× 63 1.8k

Countries citing papers authored by Caroline L. Bellac

Since Specialization
Citations

This map shows the geographic impact of Caroline L. Bellac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline L. Bellac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline L. Bellac more than expected).

Fields of papers citing papers by Caroline L. Bellac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline L. Bellac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline L. Bellac. The network helps show where Caroline L. Bellac may publish in the future.

Co-authorship network of co-authors of Caroline L. Bellac

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline L. Bellac. A scholar is included among the top collaborators of Caroline L. Bellac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline L. Bellac. Caroline L. Bellac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dufour, Antoine, Caroline L. Bellac, Ulrich Eckhard, et al.. (2018). C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease. Nature Communications. 9(1). 2416–2416. 68 indexed citations
2.
Eckhard, Ulrich, Pitter F. Huesgen, Oliver Schilling, et al.. (2016). Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14. Data in Brief. 7. 299–310. 24 indexed citations
4.
Bellac, Caroline L., et al.. (2015). The role of isoagglutinins in intravenous immunoglobulin–related hemolysis. Transfusion. 55(S2). S13–22. 28 indexed citations
5.
Bellac, Caroline L., Antoine Dufour, Michael J. Krisinger, et al.. (2014). Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis. Cell Reports. 9(2). 618–632. 93 indexed citations
6.
Christen, Stephan, Caroline L. Bellac, Fabrícia Lima Fontes-Dantas, et al.. (2014). The kynurenine pathway is involved in bacterial meningitis. Journal of Neuroinflammation. 11(1). 169–169. 33 indexed citations
7.
Zysset‐Burri, Denise C., Caroline L. Bellac, Stephen L. Leib, & Matthias Wittwer. (2013). Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis. BMC Infectious Diseases. 13(1). 393–393. 20 indexed citations
9.
Starr, Amanda E., Caroline L. Bellac, Antoine Dufour, Verena Goebeler, & Christopher M. Overall. (2012). Biochemical Characterization and N-terminomics Analysis of Leukolysin, the Membrane-type 6 Matrix Metalloprotease (MMP25). Journal of Biological Chemistry. 287(16). 13382–13395. 82 indexed citations
10.
Keller, Ulrich auf dem, Caroline L. Bellac, Claudia Broder, et al.. (2012). The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10. Cellular and Molecular Life Sciences. 70(2). 309–333. 105 indexed citations
11.
Li, Ying, Richard Ting, Curtis Harwig, et al.. (2011). Towards kit-like 18F-labeling of marimastat, a noncovalent inhibitor drug for in vivo PET imaging cancer associated matrix metalloproteases. MedChemComm. 2(10). 942–942. 40 indexed citations
12.
Keller, Ulrich auf dem, Caroline L. Bellac, Ying Li, et al.. (2010). Novel Matrix Metalloproteinase Inhibitor [18F]Marimastat-Aryltrifluoroborate as a Probe for In vivo Positron Emission Tomography Imaging in Cancer. Cancer Research. 70(19). 7562–7569. 69 indexed citations
13.
Bellac, Caroline L., Roney S. Coimbra, Stephan Christen, & Stephen L. Leib. (2010). Inhibition of the Kynurenine-NAD+Pathway Leads to Energy Failure and Exacerbates Apoptosis in Pneumococcal Meningitis. Journal of Neuropathology & Experimental Neurology. 69(11). 1096–1104. 19 indexed citations
15.
Bellac, Caroline L., et al.. (2007). Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. Neurobiology of Disease. 28(2). 175–183. 22 indexed citations
16.
Bellac, Caroline L., Denis Grandgirard, Matthias Wittwer, et al.. (2007). P806 Assessment of tryptophan metabolism and cytokine profile in cerebrospinalfiuid samples from patients with bacterial meningitis. International Journal of Antimicrobial Agents. 29. S203–S203. 2 indexed citations
17.
Bellac, Caroline L., Roney S. Coimbra, Stephan Christen, & Stephen L. Leib. (2006). Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiology of Disease. 24(2). 395–402. 29 indexed citations
18.
Meli, Damian N., Roney S. Coimbra, Gérard Loquet, et al.. (2006). Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis. Infection and Immunity. 74(7). 3890–3896. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026